Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Aminolevulinic Acid × Sarcoma × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Terminated 2 Completed 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1 Genitourinary 1

Conditions

Interventions

Doxorubicin 7 Cyclophosphamide 6 X-Rays 3 Vincristine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Ifosfamide 3 polatuzumab vedotin 2 pemigatinib 2 liposomal doxorubicin 2 glofitamab 2 fludarabine 2 envafolimab 2 anlotinib 2 Radiotherapy 2 Prednisone 2 Injections 2 Imatinib Mesylate 2 Etoposide 2 Biopsy 2 AZD 6244 2 toripalimab 1 surufatinib 1 relmacabtagene autoleucel 1 regorafenib 1 perflutren 1 pazopanib 1 obinutuzumab 1 montelukast 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡